Please provide your email address to receive an email when new articles are posted on . Autologous dermal fibroblasts may decrease risk of rotator cuff retears after arthroscopic rotator cuff repair ...
Two European firms team up to lead RepliCel's next-generation dermal injector (RCI-02) to market-ready status VANCOUVER, Feb. 28, 2017 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB:REPCF) (TSXV:RP ...
RepliCel Life Sciences Inc., a clinical stage regenerative medicine company, announced the granting of two patents in Europe related to its multi-needle dermal injection technologies. The first patent ...
A new study examines dermal injections and their impact on skin aging. Chronic exposure of human skin to ultraviolet light causes premature aging, or photoaging. As the skin undergoes photoaging, type ...
VANCOUVER, BC / ACCESSWIRE / August 2, 2022 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in ...
The product marks a new era for dermal injections with long-lasting hydration to improve skin quality from the inside out. Prollenium, a global leader in medical aesthetic technology, launches Renew™+ ...
What was supposed to be a series of wrinkle correction procedures ended up becoming a life-altering nightmare for a Florida woman. Carol Bryan decided to get dermal injections back in 2009 in the hope ...
Explore what clinical research actually says about dermal fillers, dispelling common myths and fears with evidence-based facts on safety, results and side effects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback